Oramed to Present at H.C. Wainwright 6th Annual Israel Conference

NEW YORK, Nov. 10, 2020 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that CEO Nadav Kidron will present a company overview at the H.C. Wainwright 6th Annual Israel Conference.  Presentation Details: H.C. Wainwright 6th Annual Israel Conference Presenter:  […]